Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.
about
Transmyocardial laser revascularization versus medical therapy for refractory anginaTransmyocardial laser revascularization versus medical therapy for refractory anginaTransmyocardial revascularization devices: technology updateCurrent medical management of chronic stable anginaTransmyocardial laser revascularization.Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstrictionDoes laser type impact myocardial function following transmyocardial laser revascularization?Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessorsMyocardial laser revascularization in the year 2000 as seen by a Norwegian specialist panel. The process of evaluating and implementing new methods in clinical practice.Combined percutaneous biosense-guided laser myocardial revascularization and coronary intervention.Angiogenesis three months after clinical transmyocardial laser revascularization using an excimer laser.Angiogenic therapy for coronary artery and peripheral arterial disease.Lasers in the treatment of ischaemic heart disease.Excimer laser (308 nm) based transmyocardial laser revascularization: effects of the lasing parameters on myocardial histology.The vascular response induced by transmyocardial laser revascularization is determined by the size of the channel scar: Results of CO2, holmium and excimer lasers.Treatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation.Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-upMyocardial laser revascularization--the end of a new therapy?Holmium:YAG laser system for transmyocardial revascularization.Spinal cord stimulation: a comparison of efficacy versus other novel treatments for refractory angina pectoris.Transmyocardial revascularization: peril and potential.Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial.Percutaneous coronary revascularization in patients with formerly "refractory angina pectoris in end-stage coronary artery disease" - not "end-stage" after allMid term results after bone marrow laser revascularization for treating refractory angina.Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging.Therapeutic angiogenesis in critical limb and myocardial ischemia.Development and validation of a short version of the Seattle angina questionnaire.Treatment of refractory anginaThe Seattle angina questionnaire: reliability and validity in women with chronic stable angina.Improved myocardial perfusion after transmyocardial laser revascularization in a patient with microvascular coronary artery disease.Evolving treatment strategies for chronic refractory angina.Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease.Emerging medical treatment for angina pectoris.Therapeutic angiogenesis for the management of refractory angina: current concepts.Blinding in randomized clinical trials: imposed impartiality.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiTreatment of refractory angina in patients not suitable for revascularization.Myometrial cells induce angiogenesis and salvage damaged myocardium.Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles.Long-term survival in patients with refractory angina.
P2860
Q24187921-F59B5E12-03D2-476B-8E12-D18A38A34A33Q24241454-261A3DDA-0D4C-4E10-B993-3601DE51CC22Q26865489-18493DCC-80CB-44DC-A099-B6590625075CQ28213164-4A1DCD6C-BC59-4485-8952-E7851E76845FQ30426510-03B96AA6-9B10-4E0F-B23D-930480776B53Q30443269-5885A28F-781B-425F-9D07-81C9AE78E674Q30464981-DF4FC1AD-D928-4591-A817-CCB4B9AD9329Q30537204-AAE7D379-3DA2-4A0F-8874-2CBC046DC6D0Q30667906-5E08B319-90FE-44E7-9C4C-F9B35D1BCBA7Q30672803-2A090142-821C-4337-919A-0E7E274D17CEQ30779441-283F3A55-6851-4B9A-AA65-A9DEEF9A3500Q30783593-01DC8F64-D226-4CA6-ADE0-1332C32D996FQ30858227-FA343A55-5034-4E15-86B6-6B76750EA9ABQ31001275-8614AF60-1312-4536-B900-771300BECF74Q31101269-4FF26B15-55BA-48C0-937B-15D62D4B03F1Q31112721-271A64AE-8764-4AC3-898D-08CA4FC4E0B1Q31131911-1EDE2440-6DFC-4477-B3BA-D4CA20112A90Q31915873-90976BFF-9C2D-4178-9AE9-D10B2BB11F79Q33235394-A20F2C35-EF57-4C06-93B3-73037313E6A0Q33264719-687E8EC6-B7FF-4319-BECE-D80701543804Q33284351-2B8F34C2-0C1C-4853-91BC-ADD45C6CA339Q33347861-5D1B8882-4EE7-4ED4-9D78-2179878E835AQ33498122-27FA8D69-203C-4D7B-BE75-3616FF1F847CQ33694829-F8EA733B-1574-4966-BDF9-F3BCCCE5091DQ33709121-2B0CBD47-5F4F-4375-B011-40BD31C7241FQ34675242-F836F63F-8C6B-4FB7-AC82-8ADC70CA36DCQ34807134-F79661DB-8DCA-4F13-A85D-97D08B229438Q34986448-16E7ADCA-0C4C-488E-BBD5-46A020BF71BDQ35065844-28716790-C2CB-4068-BBD5-AF85AD0038ABQ36094568-9629FAE7-342E-48F2-90C0-D1FFB3D40A94Q36382563-6B0CC8B7-6065-429E-BBF7-E4DBD7001E54Q37661212-A2D96380-9E93-435B-9D95-DDF5EAD6E9E2Q37729183-49D28752-4224-4725-BFEC-93D2063091E3Q37734560-D155DC6A-A916-447F-9A97-1C257FBF97B5Q37945039-CCFBD047-0297-4D8D-A722-C539142D1939Q37953885-AF11ED0A-39AE-4D14-9B3C-E2B16CC21CC1Q38173640-A5767E93-DB97-44AE-ADF1-09183F7132B9Q38483643-D47389BE-E93B-414C-BDBF-D80B9533C17EQ38860377-0B922DF9-F84C-4F6F-951C-C8E35B852B33Q39227491-FF0F77D0-B610-4A54-BC29-716D7D813339
P2860
Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Transmyocardial laser revascul ...... ormal Therapies in Comparison.
@ast
Transmyocardial laser revascul ...... ormal Therapies in Comparison.
@en
type
label
Transmyocardial laser revascul ...... ormal Therapies in Comparison.
@ast
Transmyocardial laser revascul ...... ormal Therapies in Comparison.
@en
prefLabel
Transmyocardial laser revascul ...... ormal Therapies in Comparison.
@ast
Transmyocardial laser revascul ...... ormal Therapies in Comparison.
@en
P2093
P1433
P1476
Transmyocardial laser revascul ...... ormal Therapies in Comparison.
@en
P2093
D Burkhoff
L C Becker
S P Schulman
P304
P356
10.1016/S0140-6736(99)08113-1
P407
P577
1999-09-01T00:00:00Z